| 注册
首页|期刊导航|医药导报|我国试验用药品管理成本探析

我国试验用药品管理成本探析

倪小清 任智文 宋玉洁 尹琪楠 何林

医药导报2025,Vol.44Issue(6):1016-1020,5.
医药导报2025,Vol.44Issue(6):1016-1020,5.DOI:10.3870/j.issn.1004-0781.2025.06.030

我国试验用药品管理成本探析

Management Costs of Drugs for Clinical Trials in China

倪小清 1任智文 1宋玉洁 1尹琪楠 1何林1

作者信息

  • 1. 四川省医学科学院·四川省人民医院药学部(药物临床试验中心),成都 610072
  • 折叠

摘要

Abstract

According the Good Clinical Practice(GCP)and programmatic requirements,we analyze the management characteristics and the costs of drugs for clinical trials in different specialties from the drug management;The characteristics of the management of drugs for different specialties was summarize and the differential factors that may affect the management cost was explored,so as to provide theoretical support for the research institutions to utilize the resources in a rational and efficient way.This article provides a guarantee for the drug management with the aim of enhancing the quality and efficiency of clinical trials.

关键词

临床试验用药品/管理特点/管理成本

Key words

Drugs for clinical trials/Management characteristics/Management costs

分类

医药卫生

引用本文复制引用

倪小清,任智文,宋玉洁,尹琪楠,何林..我国试验用药品管理成本探析[J].医药导报,2025,44(6):1016-1020,5.

基金项目

四川省人民医院院基金(2023RKX06). (2023RKX06)

医药导报

OA北大核心

1004-0781

访问量0
|
下载量0
段落导航相关论文